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Tissue amyloid P component (TAP), a protein that 
crossreacts immunohistochemically with the normal plasma 
glycoprotein serum amyloid P component (SAP), is invari-
ably associated with elastic fiber microfibrils in adult humans. 
We have investigated the nature of this association. Aliquots 
of minced, homogenized dermis, obtained following ethy-
lenediamine tetraacetic acid (EOTA) separation of whole 
adult human skin, were extracted with different tea gents, 
and the presence or absence of TAP in the pellet and in the 
supernatant following centrifugation was determined by 
SOS-PAGE and immunoblotting using anti-SAP antibodies. 
TAP was extractable from dermis using reagents which 
disru£t non-covalent bonds, including sodium dodecyl sul-
fate (SOS) and guanidine hydrochloride. TAP was not ex-
tracted by high molarity salt solutions, non-ionic detergents, 
or the reducing agents dithiothreitol and 2-mercaptoethanol. 
Amyloid P compenent (AP) is a glycoprotein found in tissue deposits of all forms of amyloid in which it has been sought, including the various rypes of cutaneous amyloidosis, with the single exception of the intracor-tical plaques in Alzheimer's disease [1-4]. AP is indis-
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EOTA solution was similarly unsuccessful at eluting TAP 
from the dermal preparation, indicating that the association 
of TAP with elastic fiber microfibrils is not simply the result 
of Ca++-dependent binding. Collagenase solubilized some 
TAP, bue this does not prove covalent linkage to elastic tissue 
of part of the TAP, because the afparent M, ofT AP extracted 
was identical to that of norma SAP subunits. We cannot 
completely exclude the possibiliey that a few subunits in each 
multimeric TAP molecule are covalenrly attached to the mi-
crofibrils. However, our findings that denaturing agents 
alone extracted most of the TAP from normal human dermis 
strongly suggest that the great majority of the dermal TAP is 
non-covalently bound to elastic fiber microfibrils. Thus TAP 
is not an imegral constitucem of elastic fiber microfibrils. J 
ltlllest Derrnaro/92:53-58, 1989 
tinguishable from, and derived from. the normal r.1asma glycopro-
tein serum amyloid P compenent (SAP) 11,5,6 . SAP, which is 
synthesized by hepatocytes [71, is compesed of 1 0 identical glycosyl-
ated polypeptide subunits of approximate molecular weight of 
25,000 daltons, non-covalently associated together in the form of 
two pentameric discs interacting face-to-face. SAP closely resem-
bles C-reactive protein (CRP), the classical acute phase reactant, in 
terms of molecular configuration. ultrastructural appearance, and 
amino acid sequence. SAP and CRP together form a distinct family 
of proteins of common evolutionary origin termed pentraxins, and 
are encoded for by homologous genes that have been mapped to the 
same region of the long arm of human chromosome 1 [8 - 10]. SAP 
may be extracted from normal human serum by virtue of its Ca++-
dependent affinity for agarose, the result of binding to the pyruvate 
acetal of galactose [11-13]. SAP exhibits specific Ca++-dependent 
binding to a variery of other ligands, including fibronectin. C4 
binding protein, some glycosaminoglycans, keratin filament aggre-
gates. and DNA and chromatin, in addition to isolated amyloid 
fibrils in vitro [14 - 191. 
In addition to the universal presence of AP in dcpo:siu of amyloid, 
and the occurrence of SAP as a normal plasma protein, a protein that 
cross-reacts immunochemically with SAP has been shown to be a 
normal matrix glycoprotein of glomerular basement membrane, in 
which it is covalently linked to collagen and/ or other matrix pro-
teins [20]. We have shown in immunohistochemical studies that 
this normal tissue fonn of amyloid P component (TAP) is also 
invariably associated with elastic fiber microflbrils in normal adult 
human skin and other tissues [2,21,22], and that alterations in the 
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staining parcern with anti-SAP correlate with abnormalities of the 
microfibrillar component of elastic fibers in disease states [23]. In 
man, the presence of TAP in normal skin is age-related. because 
TAP is first readily detected in association with elastic fibers from 
age 4 onwards [24]. 
The significance of the association between TAP and e1ascic fiber 
microfibrils is unknown. One group speculated that molecules of 
TAP may form the tubular core of the microfibrils, on the basis of 
their finding that TAP is associated with microfibrils in the footpad 
and zonulae of the eye of the mouse [25]; we have never been able to 
detcct any SAP, or SAP-cross reactive antigens, in normal tissues in 
this species. SAP has been reported to act as an inhibitor of elastase, 
and it has therefore been proposed that TAP may protect elastin 
from degradation [26]. We have not, however, been able co confirm 
that SAP has elastase inhibitory properties [Pepys, unpublished 
datal. We have suggested that TAP associated with elastic fiber 
microfibrils may play an important role in the maintenance of 
denno-epidermal adhesion and connective tissue architecture 
[4.22J. via an interaction with tissue fibronectin [14,15J and glycos-
aminoglycans (16J. The close association between elastic fibers and 
deposits of amyloid in various types of cutaneous amyloidosis has 
been noted by many authors [3.27J. and. because SAP binds amyloid 
fibrils [19]. we have proposed that TAP on elastic fiber microfibrils 
may provide a nidus for deposition of amyloid material [3.4J. In 
view of the potential importance of TAP in health and disease. we 
have studied the biochemical nature of the interaction between 
TAP and elastic tissue in normal human dermis. We report here that 
the majority, if not all, of TAP in human skin is associated non-co-
valently with elastic fibre microfibrils, and that this association in-
volves morc than simple Ca++ -dependent binding. 
MATERIALS AND METHODS 
Prepara tion of SAP SAP was isolated from normal human serulll 
as previously described {1I,12J. 
Antiserum Anti-human SAP antibodies were raised by immuni-
zation of rabbits with isolated purc SAP as described [11,121. and the 
IgG fraction of rabbit anti-human SAP was obtained by staphylo-
coccal protein A absorption for use in immunoblotting studies. 
Preparation of Dermal Extracts Dermal material was obtained 
free of epidermis by incubating approximately 1.0 g of normal 
human skin obtained at surgical operations with 15 ml of 0.02M 
ethylenediamine rerraaceric acid (EOTA) buffer for 90 min at 4S0C 
as previously described [28]. Approximately 800 mg wet weight of 
dermis was minced with scissors, homogenized using a ground glass 
homogenizer. and suspended in 15 ml of Dulbecco's phosphate 
buffered saline (PBS; Gibeo, Paisley. Scotland). After two washes 
with PBS, I-ml aliquors of the dermal suspension were centrifuged 
for 15 min at 450 g, and the pellets were incubated for 4 h at room 
temperature with constant agitation with one of a battery of extrac-
tion agents listed in Table I. Following centrifugation at 450 g for 
t 5 min, extracted dermal material was divided into residual pellet 
samples and extraction supernatant samples, which were subse-
quently processed separately in parallel. In other experiments, 15 ml 
of EDTA solution, which was incubated with whole skin (in order 
[0 separate dermis from epidermis), was concentrated to 400 ,ul, and 
45 ml, of PBS used to wash approximately 800 mg of dermis (after 
mincing and homogenization) was concentrated to 650,ul (Minicon 
B 125 concentrator; Amicon Corp., Lexington, MA). The concen-
trates were then processed as below in the same way as the other 
extraction supernatant samples. Pellet samples were washed in PBS 
and then boiled for 20 min in 1,200,uL of buffer containing 
0.0625M Tris-HCL pH 6.8. 2% sodium dodecyl sulfate (SDS). 
10% glycerol. 5% 2-mercaptocthanol (2-ME). 0.01% Bromo-
phenol Dlue. and 1% Triton X-IOO ("extraction buffer"), and the 
remaining debris was removed by centrifugation. Extraction super-
natant samples were recentrifuged for 30 min at 10,000 g. and 
the supernatants were mixed with two times their volume of 
Laernmli sample buffer 129] containing 5% 2-M.E, and boiled for 10 
min. Supernatants from dermal material extracted with 2M NaCI, 
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T able I. Extraction of AP from Normal Human Dermis: 
Agents Used 
AP Present In-
Extr.lcOon Agent(s) Pellet Supematult 
IP~ ~ 
2. D.DIM EOTA. D.DIM Tris. D.14M N~CI. 
pH 8.0 ~ 
3. 2M N,CI ~ 
4. 2M N.CI. O.OIM EOTA ~ 
5. I % Triton X- tOO in PBS +" 
6. 1 % Nonidet P-4D in PBS +lo 
7. O.O IM EOTA. O.OIM Tris. 0.14M N.CI. 
O.OIM OTT. pH 8.0 ~ 
8. 2MN.CI.O.OIMEDTA.O.IMOTT ~ 
9. 2M N.cl. O.OIM EOTA. O.IM OTT. 1% 
Triton X-loo 
10.5% 2-ME 
t 1. 2M Hydroxylammonium chloride. pH 10.5 
12. 0.1% SOS in PBS 
13. 2% 50S in PBS 
14. 0.1% 50S. O.IM OTT in PBS 
15. SM Guanidine Hydrochloride pH 7.0 
16. 6M Guanidme Hydrochloride. O.5M Tris. 
0.00 I M EOTA. pH 8.5 
17. 6M Guanidine Hydrochloride, O.SM Tris, 
O.ooIM EOTA. O.IM OTT. pH 8.5 
18. I % Collagenase 
t 9. 'Extraction buffer'; 
D.0625M Tris. 2% SOS, 10% glycerol. 5% 
2-ME. 0.01% bromophenol blue, 1% Triton 
X-IOO 
+/-" 
+/-" 
+'" 
NAf 
• As delctITuned by SOS-PAGE ::.nd IInmunoblomng With alld-SAP. 
10 +: fe::.Ji ly detecfllble 
~ - : completely llbKnl 
d +/-: ::.bscm on SOS-PAGE bUllfllCC detC'cublc on LTnTnunoblomng; 
~ qU::'llrity of AP III reSldu:li ~lIel rC'duCC'd. 
f NA: nOlllpplicablc 
~ 
~ 
~ 
~ 
~ 
~ 
+b 
2M hydroxylammonium chloride, or 6M guanidine hydrochloride 
were dialyzed overnight against PBS before addition of rhe 
Laemmli sample buffer containing 5% 2-ME. Fifty microliters of 
each pellet sample and 100 JiL of each extraction supernatant sample 
were then analyzed by SOS-polyacrylamide gel electrophoresis 
(SDS-PAGE) on 10.5% continuous gcls followed by immunoblot-
ting to identify TAP as below. 
In addition, 150 mg wet weight of dermis was incubated with 
1.5 mg of collagenase type IA (from Clostridium histolyricum, 
380 U/mg; Sigma Chemical Co .. St. Louis. MO) for 18 h at 37°C. 
Oermal material was also extracted essentially according to the pro-
cedure described by Ross and Bornstein [30J for the isolarion of 
elastic fibers from fetal bovine ligamentum nuchae. In brief, 
1.500 mg of human dennis was minced with scissors. homogenized 
with a ground glass homogenizer, suspended in 50 ml of 5M guani-
dine hydrochloride buffer pH 7.0, and incubated for 24 h at room 
temperature. The buffer was changed twice during the incubation. 
and aliquors were analyzed by SOS-PAGE and immunoblotting. 
After three washes with 0.2M Tris pH 7.4, and three further washes 
with distilled water, the pellet following centrifugation was incu-
bated with 15 mg collagenase (1 % of che wet weight of the original 
dermal sample) in 0.2M Tris pH 7.4 containing O.S% penicillin-
streptomycin (Gibco) for 18 h at 37°C. washed twice with 0.2M 
Tris, and once with distilled water. The residual pellet was then 
processed for SDS-PAGE and immunoblotting. 
Immunoblotting Immunoblorcing was performed essentially as 
previously described [28,3 1,32]. Proteins transferred to nitrocellu-
lose paper were first stained with 0. 1 % Fast Green FCF (Poly-
sciences Inc .. Warrington. PA). and their position on the paper was 
marked by punching with a needle r31]. TAP was then detected 
using rabbit anti-human SAP (dilution 1: 500) followed by horse-
radish peroxidase-conjugated staphylococcal protein A (HRP-pro-
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tein A) (Kirkegaard and Perry Labs, Gaithersburg, MO) at a dilution 
of 1 : 200; the peroxidase reaction product was visualized using the 
diaminobenzidine reaction [28]. The specificity of the rabbit anti-
human SAP antibody was confirmed by immunoblotting studies 
using pure SAP (1 ,ug in 10,uL Laemmli sample buffer), or normal 
human serum as a source of SAP (20 ,uLof a 1 : 15 dilurion of normal 
human serum in Laemmli sample buffer containing 5% 2-ME). 
RESULTS 
The results of attempted extraction of TAP from normal human 
dermis using a battery of different agents are summarised in Table I. 
The presence or absence of TAP in the residual pellet and the ex-
traction supernatant preparations was determined by SOS-PAGE 
and immunoblotting. Results of representative experiments are il-
lustrated in Figs 1 and 2, respectively. Following the final treatmellt 
of the residual dermal pellets with boiling "extraction buffer," nu-
merous proteins with a wide range of molecular weights were solu-
bilized, as analyzed by SOS-PAGE (Table I, extraction agent 19; Fig 
1). TAP was identified on SDS-PAGE as a protein with an approxi-
mate molecular weight of 30 kO that co-migrated with isolated 
purified SAP (Fig 1, latl' J). The high apparent molecular weight of 
TAP/ SAP seen on SOS-PAGE is due to the anomalous behavior of 
SAP in this system as previously discussed [8] . In all instances in 
which a protein band, co-migrating with purified SAP on SOS-
PAGE, was detected in either the residual pellct or the extraction 
supernatant. it was identified as TAP on immunoblotting. as a pro-
tein that co-mjgrated with SAP in normal human serum (Fig 2, lalle 
1) and with isolated purified SAP (Fig 2, la", 2). The specificity of 
the rabbit anti-human SAP antibody used in the immunoblotting 
study was confirmed by the absence of any reactivity with other 
proteins in normal human se rum, or with any o f the numerous other 
proteins released from dermis by the "extraction buffer" (Fig 2). 
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SOS-PAGE and immunoblot analysis of concentrates of EOTA 
solution incubated with normal human skin in order to induce 
splitting, and of PBS used to wash the dermis after mincing and 
homogenization, did show trace quantities of SAP present. How-
ever, both ptcparations were visibly conram..inated by blood before 
concentration, and , moreover, the pattern on SOS-PAGE analysis 
closely resembled that obtajned on analysis of nonnal human serum 
(data not shown). TAP was not so lubilized from preparations of 
homogenized and extensively washed normal human dermis by 
extraction with PBS, further EDTA, high molar salt solution, de-
tergents, the reducing agents OTT or 2-ME., or hydroxylammon-
ium ch loride (Table I, extraction agents 1 to 11 ; Fig I ,ltmes 4-7; Fig 
2, falles 3 - 6), because TAP remained detectable only in the residual 
pellet and not in the ex tfdction supernatant. The above extraction 
agents did, however, ex tract a number of unrelated proteins which 
appeared as bands on SOS-PAGE analysis of the extraction superna-
tants (Fig I, Jall es 5 and 7). Dy contrast, TAP was detected in extrac-
tion supcrnatants following ex traction of dermis with SOS alone or 
in combination with OTT (Table I, extraction agents 12 to 14) , and 
with guanidine hydrochloride (Table I, extractio n agents 15 to 17; 
Fig 1, lllt/es 8-12; Fig 2, laPles 7- 11). Extraction of dermis with 
guanidine hydrochloride resulted in absence of many of the lower 
molecular weight protein bands on 50S-PAGE of the residual pel-
let, with a corresponding increase in low molecular weight proteins 
in the extractio n supernatant (Fig 1, lants 8-11). The finding of 
TAP in the extraction supernatants was associated with a corre-
sponding decrease in the amount of TAP in the residual pellets. 6M 
guanidine hydrochloride extracted virtually all the TAP from the 
dennis, such that TAP in the residual pellet was undetectable by 
SOS-PAGE (Fig I , latl" 8 and 10), and detectable only in trace 
amount by immullobiotting (Fig 2, la~les 7 and 9). 
Normal human dermis was also ex tracted according to the 
s p s p s p s 
7 8 9 10 11 12 13 
Figure 1. SDS~PAGE analysis of residual pellet material and extraction supernatants following extraction of nonnal human dermis usingsdected extraction 
OIge llts from among those listed in TOIbie I; proteins stained with Coomassie Blue.LAtlt 1: molecular weight markers; lane 2: normal human serum control; lant 
J: i50l:ued pure SAP control; lane 4: pellet. and lane 5: supernatant, following extncrion with 2M N2CI, O.DtM EDT A, 0.1 M OTT, 1 % TritonX-IOO; lant 6: 
pellet, and latl! 7: supernatant . following ex traction with 2M hydro xylammonium chloride pH 10.5; Jane 8 pellet. and la llt' 9: supernatant. following 
extraction with 6M guanidine hyd rochloride, O.SM Tris, 0.00 1 M EDT A pH 8.5; laltt 10: pellet. and lane 11 : supernat.ant . following ex rr.lccion with 6M 
guanidine hydrochloride. O.SM Tris. O.OOtM EDTA, 0.1 M DTT pH 8.5; latH! 12: pellet following sequential extraction with SM guanidine hydrochloride 
and collagenase; and lant 1 J : supernatant following extraction with co llagenase alone. Arrowheads denote b2nds identified as SAP by co-migration with pure 
SAP as shown in ftltle J. 
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Figure 2. Immunoblot analysis with anti-SAP of residual pellet material and extraction supernatants following extraction of normal human dermis using 
agents as shown in Fig. 1. Lwt 1: normal human serum control; lane 2: isol:ued pure SAP control: lant 3: pellet. and lant 4: supernatant, following extr.action 
with 2M NaCI. O.OIM EDTA. O.1M OTT. 1% Tricon X-tOO; lant 5: pellet. and lane 6: supernatant. following extraction with 2M hydroxylammonium 
chloride pH to .S; lane 7: pellet, and lant8: supernatant, following exttacnon with 6M guanidine hydrochloride, O.SM Tris. O.OOtM EOTA pH 8.S; lane 9: 
pellet, and lant 10: supernatant. following extraction with 6M guanidine hydrochloride, O.sM Tris. O.OOlM EOTA, O.IM OTT pH 8.5; Itmt 11: pellet 
following sequential extraction with sM guanidine hydrochloride and collagenase; and lane 12: supernaunt following extraction with collagenase alone. 
method of Ross and Bornstein [30], with SM guanidine hydrochlo-
ride followed by collagenase. TAP was detectable in the extraction 
supernatant in the first and second changes of the extraction buffer, 
bur was absent from the third change of buffer I despite the fact that 
some TAP remained detectable in the residual dennal pellet even 
after 24 h incubation with guanidine hydrochloride. This residual 
TAP was entitely extracted after further incubation with collagen-
ase, because TAP subsequently became undetectable in the residual 
pellet by SDS-PAGE and immutloblotting (Fig I, fa .. , 12; Fig 2, fa .. , 
11). In the absence of guanidine hydrochloride, collagenase treat-
ment alone of the dermis partially solubilized TAP, because TAP 
became detectable by SDS-PAGE in the extraction supernatant as 
well as in the residual pellet (Table I, extracrionagent 18; Fig 1, Jarle 
13; Fig 2, fa .. , 12). 
DISCUSSION 
Elastic tissue within the dennis is composed of three sets of inter-
connecting fibers. termed oxytalan. elaunin, and elastic fibers, re-
spectively [33]. Mature elastic fibers in the reticular dermis connect 
with a more superficial plexus of thinner e1aunin fibers running 
praUel to the dermo-epidermal junction, from which in turn thin 
oxytalan fibers run upwards in the papillary dermis, perpendicular 
to the dermo-epidennal junction, to be inserted directly into the 
basal lamina. Under the electron microscope. elastic fibers are com-
posed of a central amorphous elastin core surrounded by a peripheral 
mantle of tubular microfibrils, of approximate diameter 10 to 
14 nm, termed elastic fiber microfibrils. Ultrastructurally, oxytalan 
fibers are seen to consist of elastic fiber microfibrils only, al though 
an immunohistochemical study has reported that they also contain 
non-amorphous elastin {30,34- 37]. Elaunin fibers possess an amor-
phous central core, and are intermediate in character between elastic 
and oxytalan fibers. We have previously shown in immunoultra-
structural studies that TAP is invariably associated with elastic fiber 
microfibrils in normal adult human tissue throughout the body 
[2,21-23]. 
The relationship of TAP to other constituents of elastic fiber 
microfibrils is uncertain. Biochemical characterization of elastic 
fiber microfibrils has been hampered by the difficulty experienced 
in extracting the microfibrils in pure form, and in consequence our 
knowledge of their composition is restricted. In contrast to elastin. 
elastic fiber microfibrils are susceptible to digestion by proteolytic 
enzymes such as trypsin, chymotrypsin, and pepsin, but are resistant 
to elastase and collagenase l30.34]. Extraction of fetal bovine liga-
mentum nuchae with dithiothreitol in SM guanidine hydrochlo-
ride, which nonenzymatically solubilizes elastic fiber microfibrils, 
yields a glycoprotein preparation rich in cystine and/olar amino 
acids, but lacking hydroxyproline, hydroxylysine. an the desmo-
sines [30,34]. Ultrastructural histochemical investigation of bovine 
elastic tissue has confirmed the association of glycoproteins with 
elastic fiber microfibrils [38]. Fibroblast cultures derived from fetal 
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bovine ligamentum nuchae accumulate extracellular fibrils mor-
phologically identical to elastic fibre microfibril s. and secrete two 
glycoproteins, a collagenase sensitive protein of molecular weight 
150 kD distinct from collagen cype VI (designated MFP I) and a 
collagenase-resistant protein of molecular weight 300 kD (desig-
nated MFP II), which cross-react immunochemicaHy with elastic 
fiber microfibrillar protein [39 - 41]. MFPI and MFPII are distinct 
from TAP {21J. However, the antiserum used to monitor the cross-
reactivity of MFPI and MFPII with elastic fiber microfibril s also 
displays affinity for non-elastic tissue microfibrils, and the status of 
MFPI and MFPII as elastic fiber microfibrillar proteins has therefore 
been challenged [421. A 31 kD acidic glycoprotein termed microfi-
bril-associated glycoprotein (MAGP) has been identified as the 
major antigen of elastic fiber microfibrils extracted from fetal bo-
vine ligamentum nuchae, using immulloblocting and immunohis-
tochemical techniques [43}. MAGP was extractable using NaC I. 
urea, or guanidine hydrochloride only if the reducing agent dithio-
threitol was present, indicating that disulfide bonding is important 
for the association of MAGP with elastic fibers. On the basis of our 
current findings, TAP would appear to be extractable from elastic 
tissue under entirely different conditions to those required for the 
extraction of MAGP, confirming that MAGP is structurally and 
immunologically distinct from TAP [43J. 
The results of this study have shown that TAP is extractable from 
nonnal adult human dermis using chaotropic reagents, including 
SDS and guanidine hydrochloride, which disrupt non-covalent 
bonds. Reagents that disrupt covalent bonds, including the reducing 
agentS Dl1 (which interruptS disulfide bridges) and 2-ME, or high 
molarity salt solutions or detergents, were neither necessary nor 
sufficient for the extraction of TAP from dermis. Alchough trace 
quantities of SAP were present in concentrates of EDT A solution 
used to split whole skin and of the PBS used to wash the dermis after 
homogenization, this was 1110St likely due to contamination with 
blood. Certainly, EDTA solution was unsuccessful at eluting the 
great majority of the TAP from the dermal preparation, indicating 
that the association of TAP with elastic fiber microfibrils is nOt 
simply the result of Ca++-dependent binding. Interestingly, colla-
genase treatment alone of the dermis did result in solubilization of 
some TAP. Therefore, although our results strongly suggest that 
the majority of the TAP associated with elastic fiber micro fibrils is 
bound to the microfibrils by non-covalent linkage. we cannot en-
tirely exclude the possibility that a fraction of the TAP is covalently 
bound. 
The fact that the majority of the TAP associated with elastic fiber 
microfibrils is non-covalently bound to the microfibrils would sug-
gest that TAP is not, as has been suggested [25J. an integral constitu-
ent of the microfibrils. This is in keeping with the report that TAP 
is not present in fetal skin or in the skin of children up to 2 years of 
age [24L despite the unequivocal presence of elastic fiber microfi-
brils. It is unknown whether elastic tissue-associated AP is derived 
from SAP, or whether it is synthesized locally. We have been unable 
to confirm a report [44} that TAP is detectable by immunofluores-
cence in no rmal human cultured fibroblasts, and have failed to de-
tect TAP in fibroblast culture supernatant, despite the fact that the 
cel ls were demonStrably synthesizing Ct by radioimmunoassay 
[Reid and Pepys, unpublished datal. We have similarly been unsuc-
cessful at detecting TAP in ex tracts of fibroblasts using immuno-
blotting with anti-SAP IHintner. Pepys, and Breathnach, unpub-
lished datal . Although AP wouldappearto be non-covalently bound 
to elastic fiber microfibrils, this fact does not exclude an important 
role for elastic tissue-associated AP in the maintenance of normal 
connective tissue architecture. via its Ca++-dependent binding to 
tissue fibronectin and glycosaminoglycans, or a role in the deposi-
tion of amyloid via its binding affinity for amyloid fibril s l14 -
16,191· 
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ADVANCES IN SKIN CANCER MANAGEMENT : 
A MULTI-SPECIALTY APPROACH 
A symposium on the advances in skin cancer management: a multi-specialty approach will 
take place on February 17 - 18, 1989, aethe Ramada Renaissance Hotel, 55 Cyril Magnin Street 
(Marker at Fifrh). San Francisco. California 94102 (Tel. 415/392-8000). This program is being 
presented by rhe Department of Dcrmacoiogy and the Division of Plastic Surgery of the 
University of California School of Medicine at San Francisco. It is sponsored by UCSF's office 
of Extended Programs in Medical Education, which certifies that this activity meets the criteria 
for 10 credit hours in Category 1 of the Physician'S Recognition Award of the AMA and the 
Certificate Program of the CMA. For further infomlation or an application for enrollment, 
write to: EPMC, Registration Office, Room S7S-U. Universicy of California. San Francisco. 
CA 94143-0766 (Tel. 415/476-4251. 
